Volume 18, Number 7—July 2012
Letter
Ebola Virus Antibodies in Fruit Bats, Ghana, West Africa
Table
Location, date, fruit bat species | Sex | Age | ELISA OD (endpoint titer dilution) |
Western blot† |
|||
---|---|---|---|---|---|---|---|
REBOV | ZEBOV | REBOV | ZEBOV | ||||
Sagyimase | |||||||
May 29, 2007 | |||||||
Epomops franqueti | F | A | 0.11 (1:50) | 0.53 (1:200) | − | + | |
E. franqueti | F | SI | 0.08 (1:50) | 0.62 (1:100) | + | + | |
Hypsignathus monstrosus | F | A | 0.12 (1:50) | 1.08 (1:200) | + | + | |
H. monstrosus | F | SI | 1.11 (1:200) | 0.17 (1:50) | + | − | |
H. monstrosus | F | A | 0.15 | 0.71 | − | − | |
H. monstrosus‡ | M | SI | 0.05 | 0.11 | − | − | |
May 30, 2007 | |||||||
E. franqueti | F | A | 0.1§ | 0.53§ | − | + | |
Adoagyiri | |||||||
May 31, 2007 | |||||||
Epomophorus gambianus | M | A | 0.59 | 0.67 | − | − | |
E. franqueti§ | F | A | 0.05 | 0.16 | − | − | |
E. gambianus | F | A | 0.19 | 0.55 | − | − | |
E. gambianus | F | A | 0.13 (1:50) | 1.24 (1:800) | − | + | |
E. gambianus | F | SI | 0.65 (1:200) | 0.36 (1:50) | + | − | |
Oyibi | |||||||
June 2, 2007 | |||||||
E. gambianus | M | A | 0.51 | 0.63 | − | − | |
Negative control (RAB691/d0) | 0.19 | 0.27 | |||||
Positive control (RAB691/EBOV-N) | 1.39 | 1.42 | + | + |
*ZEBOV, Zaire Ebola virus; REBOV, Reston Ebola virus; OD, optical density; A, adult; SI, sexually immature.
†Only serum samples with ZEBOV- or REBOV- positive ELISA results (optical density >0.50) were tested.
‡Negative-control field serum samples.
§Additional serum was not available for endpoint titer dilution determination.
Page created: June 14, 2012
Page updated: June 14, 2012
Page reviewed: June 14, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.